Virtual clinical trials have come into their own thanks to widespread technology enabling patients of every background to input their experiences at the tap of a button. Science37 capitalizes on that trend by providing qualified patients free tools to participate from the comfort of their own home and the company has just raised $29 million in Series C funding to help it reach new audiences.… Read Morevia Zero Tech Blog
